27 March 2024
KHCB Tier 1 Sukuk Limited
Notice of Redemption of Certificates
NOT FOR DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA (OR TO U.S. PERSONS), AUSTRALIA, CANADA OR JAPAN, OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES OF SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
NOTHING IN THIS ANNOUNCEMENT CONSTITUTES OR CONTEMPLATES AN OFFER OF, AN OFFER TO PURCHASE OR THE SOLICITATION OF AN OFFER TO SELL SECURITIES IN THE UNITED STATES OR ANY OTHER JURISDICTION. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933 (THE "SECURITIES ACT"), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION OF THE UNITED STATES.
U.S.$159,151,000 Additional Tier 1 Capital Certificates (the "Certificates") of KHCB Tier 1 Sukuk Limited (the "Issuer")
Notice is hereby given to the holders of the Certificates that, pursuant to the terms and conditions dated 29 July 2020 (as amended) (the "Conditions"), the Issuer will exercise its right to redeem all outstanding Certificates on 28 March 2024. Accordingly, on 28 March 2024, all the Certificates shall, at the option of the Certificateholders, be converted into Ordinary Shares or redeemed. The admission of the Certificates to trading on the International Securities Market of the London Stock Exchange plc will be cancelled on, or shortly after, 28 March 2024.
Unless the context otherwise requires, capitalised terms used in this Announcement and not otherwise defined herein have the same meanings given to them in the Conditions.
For further information, please contact:
KHCB Tier 1 Sukuk Limited
Walkers Fiduciary Limited
190 Elgin Avenue
George Town
Grand Cayman KY1-9008
Cayman Islands
Telephone: +1 345 814 7600
Dated: 27 March 2024
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
